With the analysis among 1,179 patents, we discovered top 241 key players by total patent application. Merck Frosst Canada & Co., Enanta Pharmaceuticals, Inc., Merck Canada, Inc. are dominant in this area. They take 12.72% of the total patent filing.
Merck Frosst Canada & Co.
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 42
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 30
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 22
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 19
New Jersey, United States
Patent: 19
Viking Therapeutics, Inc.
California, United States
Patent: 18
With the analysis among 70 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Espervita Therapeutics, Inc., Standigm Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 19
New York, United States
Patent: 2
California, United States
Patent: 2
Intarcia Therapeutics, Inc.
California, United States
Patent: 1
Mazowieckie, Poland
Patent: 1
Rivus Pharmaceuticals, Inc.
Virginia, United States
Patent: 1
With the analysis among related 600 patents applied in the last 5 years. We discover 218 most active companies in this area. The fast-growing Enanta Pharmaceuticals, Inc., Institut National de la Santé et de la Recherche Médicale, Espervita Therapeutics, Inc. take 13.50% of patent filing during this period.
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 42
Institut National de la Santé et de la Recherche Médicale
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 19
Jiangsu Sheng, China
Patent: 14
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 13
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 12
Viking Therapeutics, Inc.
California, United States
Patent: 11
Assistance Publique des Hôpitaux de Paris SA
With the analysis among related 600 patents in last 5 years, we discover 154 new entrants. Enanta Pharmaceuticals, Inc., Espervita Therapeutics, Inc., Standigm Co. Ltd. are the most active new entrants in this area.
Enanta Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 42
Espervita Therapeutics, Inc.
Michigan, United States
Patent: 19
Société des Produits Nestlé SA
Vaud, Switzerland
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6
Karl-Franzens-Universitaet Graz
With the analysis among 505 patents, we discovered top 115 universities and scientific research institutions by total patent application. Consejo Superior de Investigaciones Científicas, President & Fellows of Harvard College, Jiangnan University are dominant in this area. They take 14.85% of the total patent filing.
Consejo Superior de Investigaciones Científicas
President & Fellows of Harvard College
Massachusetts, United States
Patent: 24
Jiangsu Sheng, China
Patent: 16
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 10
New York, United States
Patent: 7
Devon, United Kingdom
Patent: 7
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 6